OverviewSuggest Edit

PerkinElmer provides products, services, and solutions to the diagnostics, research, environmental, industrial, food, and laboratory services markets. The Company operates in two segments, Discovery and Analytical Solutions, and Diagnostics. The Discovery and Analytical Solutions segment offers analytical technologies, solutions, and services for the environmental market that enable its customers to understand the characterization and health of various aspects, including air, water, and soil. The Diagnostics segment provides instruments, reagents, and software test and screen products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used in diagnosing genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, infertility, and various metabolic conditions.

TypePublic
Founded1931
HQWaltham, US
Websiteperkinelmer.com
Employee Ratings3.1

Latest Updates

Employees (est.) (Dec 2018)12,500(+14%)
Job Openings653
Revenue (FY, 2018)$2.8 B(+24%)
Share Price (Dec 2019)$92.2

PerkinElmer Office Locations

PerkinElmer has offices in Waltham, Akron, American Fork, Billerica and in 17 other locations
Waltham, US (HQ)
940 Winter St
Akron, US
520 S Main St #2502
American Fork, US
732 E 930 S #120
Billerica, US
331 Treble Cove Rd, North Billerica
Boston, US
549 Albany St
Branford, US
29 Business Park Dr
Show all (21)

PerkinElmer Financials and Metrics

PerkinElmer Revenue

PerkinElmer's revenue was reported to be $2.78 b in FY, 2018
USD

Revenue (Q3, 2019)

706.9m

Gross profit (Q3, 2019)

342.3m

Gross profit margin (Q3, 2019), %

48.4%

Net income (Q3, 2019)

58.6m

Market capitalization (2-Dec-2019)

10.2b

Closing stock price (2-Dec-2019)

92.2

Cash (29-Sept-2019)

393.0m

EV

12.3b
PerkinElmer's current market capitalization is $10.2 b.
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

2.1b2.2b2.2b2.3b2.1b2.3b2.8b

Revenue growth, %

3%1%(6%)7%

Cost of goods sold

763.0m1.1b1.2b1.4b

Gross profit

1.4b1.0b1.1b1.3b
Quarterly
USDQ1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q3, 2015Q2, 2015Q3, 2016Q1, 2016Q2, 2016Q1, 2017Q2, 2017Q3, 2018Q2, 2019Q3, 2019

Revenue

510.9m521.8m509.6m505.4m543.3m674.3m722.5m706.9m

Cost of goods sold

278.9m283.0m278.9m280.5m301.0m342.0m374.7m364.6m

Gross profit

232.0m238.8m230.7m224.9m242.3m332.3m347.8m342.3m

Gross profit Margin, %

45%46%45%44%45%49%48%48%
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

171.4m173.2m174.8m237.9m359.3m202.1m

Accounts Receivable

457.0m470.0m470.6m439.0m425.6m552.3m

Prepaid Expenses

95.6m

Inventories

247.7m288.0m246.8m351.7m
Quarterly
USDQ1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q3, 2015Q2, 2015Q3, 2016Q1, 2016Q2, 2016Q1, 2017Q2, 2017Q3, 2018Q2, 2019Q3, 2019

Cash

144.8m171.4m170.8m125.9m112.5m132.3m224.1m205.3m203.7m168.9m195.1m192.2m311.7m210.7m248.1m288.3m616.3m149.5m150.0m393.0m

Accounts Receivable

407.9m389.5m394.9m410.8m434.8m428.5m443.0m443.7m427.0m415.4m414.2m425.7m443.3m436.8m435.8m411.1m440.4m551.4m654.5m646.3m

Prepaid Expenses

103.4m92.3m113.6m100.3m99.8m110.4m119.0m117.3m

Inventories

251.9m244.4m261.4m259.8m259.5m278.4m279.0m278.0m281.6m291.1m313.0m304.8m306.0m314.1m300.3m264.6m275.1m354.2m414.3m391.8m
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

69.9m167.2m157.8m212.4m234.3m292.6m237.9m

Depreciation and Amortization

126.9m128.5m116.7m112.0m100.0m105.0m180.6m

Inventories

(8.2m)(17.9m)(30.2m)

Accounts Payable

(7.9m)(1.8m)8.1m(16.1m)30.7m34.3m8.9m
Quarterly
USDQ1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q3, 2015Q2, 2015Q3, 2016Q1, 2016Q2, 2016Q1, 2017Q3, 2018Q2, 2019Q3, 2019

Net Income

22.6m56.2m85.8m32.2m60.1m100.3m34.2m84.7m127.0m40.3m54.9m49.0m58.1m47.5m63.9m38.6m166.6m104.5m163.1m

Depreciation and Amortization

32.0m64.2m94.8m30.6m62.8m96.5m29.4m57.9m86.8m133.4m103.8m157.1m

Inventories

(13.0m)(12.7m)(24.4m)(16.2m)(17.5m)(31.8m)(17.7m)(15.7m)(28.5m)313.0m304.8m306.0m314.1m300.3m264.6m(41.3m)(50.4m)(48.4m)

Accounts Payable

(11.7m)1.6m(18.6m)4.9m3.5m(6.0m)904.0k(11.9m)(4.0m)149.7m170.7m162.3m159.5m156.4m158.1m(36.6m)(40.0m)(34.0m)
USDY, 2019

EV/CFO

82.7 x

Financial Leverage

2.4 x
Show all financial metrics

PerkinElmer Revenue Breakdown

Embed Graph

PerkinElmer revenue breakdown by business segment: 69.9% from Discovery & Analytical Solutions and 30.1% from Diagnostics

PerkinElmer revenue breakdown by geographic segment: 62.9% from International and 37.1% from U.S.

PerkinElmer Online and Social Media Presence

Embed Graph

PerkinElmer News and Updates

PerkinElmer to Present at Stifel 2019 Healthcare Conference

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Stifel 2019 Healthcare Conference on Wednesday, November 20, 2019 at 11:30 a.m. ET at the Lotte New York Palace Hotel.read more

PerkinElmer and EverlyWell Announce Collaboration to Expand U.S. At-Home Health Test Market

Combines PerkinElmer’s expertise in immunodiagnostic testing and state-of-the-art genomics program with EverlyWell’s consumer health offerings.read more

Global Markets for Raman Spectroscopy, 2019-2023 with Profiles of Agilent Technologies, Bruker, PerkinElmer, Smiths Detection, and Thermo Fisher Scientific

DUBLIN, April 8, 2019 /PRNewswire/ -- The "Global Markets for Raman Spectroscopy" report has been added to ResearchAndMarkets.com's offering. The report forecasts the market size for Raman spectroscopy used in end applications including life sciences, material sciences, carbon materials,...

Global Microfluidics Market Forecasts, 2019 to 2024 - Leading Players are Danaher Corporation, PerkinElmer, Agilent Technologies, Bio-Rad Laboratories, and Thermo Fisher Scientific

DUBLIN, March 21, 2019 /PRNewswire/ -- The "Microfluidics Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering. The global microfluidics market was valued at USD 4,748.18 million in 2018, and is estimated to be valued at USD...

Global Microarray Analysis Market Report 2018-2023 Featuring Thermo Fisher Scientific, Agilent Technologies, Molecular Devices, PerkinElmer, Illumina, GE, and Bio-Rad Labs

DUBLIN, Feb. 14, 2019 /PRNewswire/ -- The "Microarray Analysis Market by Product & Service (Consumables, Instrument, Software, Services), Type, Application (Research), End User (Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies) - Global Forecast to 2023" report has been...
Show more

PerkinElmer Blogs

PerkinElmer Solution to Analyze Microplastics During Two Year, All-Women Research Voyage of World’s Oceans

Spectrum Two™ FT-IR spectrometer and software part of scientific collaboration with eXXpedition   WALTHAM, Mass. – November 14, 2019 – PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, announced its Spectrum Two™ FT-IR spectrometer solution is onboard a research

PerkinElmer Announces Financial Results for the Third Quarter of 2019

Revenue of $706.9 million ; 5% Reported growth; Organic growth of 5% GAAP EPS from continuing operations of $0.53 ; Adjusted EPS of $1.06 GAAP operating income margin from continuing operations of 11.1%; Adjusted operating income margin from continuing operations of 21.6% Acquisition of Meizheng

PerkinElmer Genomics’ Clinical Labs in U.S. and Malaysia to Process Samples with Vanadis Fully Automated NIPT Platform

Technology Provides Pregnant Women Widespread NIPT Access WALTHAM, Mass. --(BUSINESS WIRE)--Oct. 29, 2019-- PerkinElmer, Inc. , (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that PerkinElmer Genomics will begin processing samples with the Vanadis ®

PerkinElmer to Present at Wolfe Research Healthcare Conference

WALTHAM, Mass. --(BUSINESS WIRE)--Oct. 25, 2019-- PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Wolfe Research Healthcare Conference on Wednesday, November 6, 2019 , at 8:00 a.m.

PerkinElmer Launches PG-Seq™ Rapid Non-Invasive Preimplantation Genetic Testing Kit as Alternative to IVF Embryo Biopsies

PerkinElmer Launches PG-Seq™ Rapid Non-Invasive Preimplantation Genetic Testing Kit as Alternative to IVF Embryo Biopsies jennifer.segal… Mon, 10/14/2019 - 10:35 PerkinElmer Launches PG-Seq™ Rapid Non-Invasive Preimplantation Genetic Testing Kit as Alternative to IVF Embryo Biopsies …

PerkinElmer’s New Paddy Rice Analysis Technology Unites Image and Pressure Testing

PerkinElmer’s New Paddy Rice Analysis Technology Unites Image and Pressure Testing Liz.McPherson@… Fri, 10/11/2019 - 16:45 PerkinElmer’s New Paddy Rice Analysis Technology Unites Image and Pressure Testing October 17, 2019 at 9:45 AM EDT This release is a ba…
Show more

PerkinElmer Frequently Asked Questions

  • When was PerkinElmer founded?

    PerkinElmer was founded in 1931.

  • How many employees does PerkinElmer have?

    PerkinElmer has 12,500 employees.

  • What is PerkinElmer revenue?

    Latest PerkinElmer annual revenue is $2.8 b.

  • What is PerkinElmer revenue per employee?

    Latest PerkinElmer revenue per employee is $222.2 k.

  • Who are PerkinElmer competitors?

    Competitors of PerkinElmer include Thermo Fisher Scientific, Bruker Corporation and Tecan.

  • Where is PerkinElmer headquarters?

    PerkinElmer headquarters is located at 940 Winter St, Waltham.

  • Where are PerkinElmer offices?

    PerkinElmer has offices in Waltham, Akron, American Fork, Billerica and in 17 other locations.

  • How many offices does PerkinElmer have?

    PerkinElmer has 21 offices.